Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

about

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy Proton pump inhibitors: Risks of long-term use.Use of proton pump inhibitors in general practice.Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care.

P2860

Q26852535-340EF9F9-2EBA-4171-B2A0-AB66EFEAF30B Q34549406-637BDEF6-7A92-4C0C-A80C-5486C3B98A22 Q38614998-594DF9CD-4E03-422D-A367-B11066153E17 Q48666627-4DB833EA-D3EB-460A-9289-871C77BFF45D

P2860

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

Item

http://www.wikidata.org/entity/Q44999184

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@en

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@nl

type

Item

label

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@en

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@nl

prefLabel

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@en

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@nl

P1476

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

@en

P2093

David A Johnson

http://www.w3.org/2001/XMLSchema#string

Harley R Liker

http://www.w3.org/2001/XMLSchema#string

Robert Chilton

http://www.w3.org/2001/XMLSchema#string

P2860

Antiplatelet therapy and proton pump inhibition: clinician update

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

Q28217745

Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.

Clopidogrel with or without omeprazole in coronary artery disease.

P304

239-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2014.05.2772

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24918808

http://www.w3.org/2001/XMLSchema#string

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

about

P2860

P2860

Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698